The 1% odds suggest traders believe Week 19 hospitalization rates will diverge from the 80-85 range. Week 19 of 2026 (mid-May) typically falls during late spring when U.S. influenza activity is generally declining as colder months end. The CDC tracks weekly hospitalization rates per 100,000 population through its surveillance system. This narrow range represents moderate transitional activity, well below winter peaks but elevated above summer baseline. The extremely low odds indicate strong consensus that actual rates will fall either well below 80—consistent with typical spring decline—or above 85 if a late-season surge occurs. The market closes May 22, giving traders about one week to assess CDC releases and emerging trends. Current liquidity of $5,364 reflects moderate interest in this specific outcome band.
Deep dive — what moves this market
Influenza hospitalization rates in the United States follow a distinct seasonal pattern, peaking during winter months (December through February) when cold weather, low humidity, and increased indoor contact maximize viral transmission. By Week 19 of 2026, which falls in mid-May, the seasonal flu epidemic enters its terminal decline phase. Historical data shows winter weeks regularly report hospitalization rates exceeding 200 per 100,000, reflecting peak seasonal burden, but by spring, rates typically fall toward 50-100 per 100,000 depending on variant dominance and population-level immunity. The 80-85 per 100,000 band represents moderate transitional activity—elevated above typical summer baseline but well below sustained winter levels. The CDC publishes official hospitalization estimates through its National Healthcare Safety Network (NHSN) surveillance system with a standard lag of 1-2 weeks; final Week 19 data directly determines market resolution.
Multiple epidemiological and behavioral factors influence where Week 19 hospitalization rates ultimately land. First, variant emergence and dominance: if a novel reassortant flu strain with increased respiratory severity emerges and circulates in spring, hospitalization rates could remain elevated above 85 despite declining overall case counts. Second, vaccination coverage dynamics: flu vaccine effectiveness declines significantly throughout a season as immune response wanes; late-season vaccination campaigns or waning immunity patterns directly affect hospitalization risk. Third, behavioral transition effects: schools resuming spring activities, end-of-year travel and gatherings, and seasonal agricultural work resumption all alter transmission patterns and healthcare-seeking behavior. Fourth, substantial geographic variation exists—southern states experience minimal influenza activity by May due to warming temperatures, while northern regions retain active spring transmission potential and higher hospitalization rates.
The current 1% YES odds reflect overwhelming market consensus that Week 19 rates will fall outside the narrow 80-85 band. This pricing structure indicates traders expect rates to already trend well below 80 as May approaches, consistent with baseline seasonal decline assumptions. The extremely tight odds leave minimal probability that this specific narrow band will capture the actual outcome, suggesting either high confidence in the current epidemiological trajectory or assessment that an 80-85 range represents an inherently unlikely outcome given typical late-spring dynamics.
